ACCP collaborates with ASHP on Ambulatory Care Pharmacy activities.

ASHP members, please visit www.rxcertifications.org to receive member pricing.

• Series Overview
• Program Content
• Faculty and Reviewers
• Financial Relationship Disclosures
• Target Audience and Learning Objectives
• Continuing Pharmacy Education Credit
• Specialty Recertification Credit
• Technical Requirements
• Commercial Support
• Fees

The 2023 ACCP/ASHP BCACP Clinical Sessions are part of the professional development programs for recertification of the Board Certified Ambulatory Care Pharmacist and/or the Board Certified Geriatric Pharmacist approved by the Board of Pharmacy Specialties (BPS) and jointly provided by ACCP and the American Society of Health-System Pharmacists (ASHP).

This educational series explores cutting-edge, contemporary therapeutic topics, and demonstrates scientifically sound clinical reasoning and decision-making. It employs learning activities designed to advance the participants' skills and abilities to critically evaluate the scientific evidence and to effectively incorporate into daily practice significant findings that lead to effective and safe patient care.

Release date: February 7, 2024
Specialty Recertification credit expiration date: December 17, 2024
ACPE credit expiration date: December 17, 2026

The 2023 ACCP/ASHP BCACP Clinical Sessions are offered in four presentations. Each presentation focuses on a different Ambulatory Care Pharmacy/Geriatric Pharmacy topic that is highly relevant for day-to-day practice. Topics include patient access to reproductive healthcare, updates in the management of chronic kidney disease, hypercholesterolemia treatment recommendations, and treating obesity in older adults.

BCACP Clinical Session
Changing the Way Patients Access Reproductive Healthcare
There are many barriers to access to Women's Health and contraception. This session will help to decrease those barriers by providing resources to help pharmacists advocate for the expansion of laws in their state to include pharmacist contraceptive services as well as to assist pharmacists in rolling out pharmacist contraceptive services if their state already has laws in place. For states with laws in place, the uptick has been low at times. By provided case-based examples and tools readily at their disposal, pharmacists will feel more empowered to establish or expand services to include Women's Health.

BCACP/BCGP Clinical Session
Filtering Out the Old, and Reabsorbing the New: Updates in the Management of Chronic Kidney Disease
This session will provide attendees with practical information on how to individualize drug therapies for patients living with chronic kidney disease. The landscape of diagnosis and management of CKD is continually evolving, with evidence-based recommendations changing dramatically in the past few years. This session will provide an overview of these crucial and timely updates with an opportunity for attendees to apply the evidence to simulated patient cases while focusing on overcoming therapeutic inertia and advocating for equitable care.

BCACP/BCGP Clinical Session
The Cholesterol Limbo: How Low Should You Go?
This session will focus on the hypercholesterolemia treatment recommendations and recent literature supporting the role of statin and nonstatin therapy. Faculty will review clinical trial data, especially with newer agents, as well as discuss the role of pharmacists in hypercholesterolemia management. Many clinicians follow the 2018 ACC-AHA cholesterol guideline recommendations as the “gold standard” evidence-based guideline by implementing a fixed-dose, intensity-based statin treatment. This may be appropriate for many patients. However, several high-risk patients may require more intense therapy and targeting further reductions in LDL-C with nonstatin therapy including ezetimibe, PCSK9 inhibitors, bempedoic acid, inclisiran, and icosapent ethyl. This presentation highlights how low cholesterol can go safely to reduce cardiovascular risk, especially in older adults. Interactive case studies will be used to facilitate learning.

BCACP/BCGP Clinical Session
Weighing In: The Risks and Benefits of Treating Obesity in Adults and Older Adults
Although behavioral interventions are the foundation of weight management in adults, the effectiveness of these strategies may be limited. In older adults, there are limited data demonstrating that lifestyle interventions are best for both safety and efficacy. There are significant concerns that aggressive lifestyle measures for weight loss, especially through calorie restriction without resistance exercises in older adults may result in increased sarcopenia, frailty, functional decline, fractures, and malnutrition. The addition of pharmacologic therapies for long-term management of obesity may help adult patients achieve optimal outcomes. As the medications available for weight management increase, health professionals are faced with options for individualizing treatment regimens. The purpose of this session will be to review management strategies for weight loss, evaluate the latest literature on pharmacotherapy, and apply the guidance to clinical pharmacy practice in adult and older adult populations. Presenters will also discuss special considerations including pharmacokinetic and pharmacodynamic changes, polypharmacy, cognitive and functional status, caregiver involvement and care venues, food insecurity, and socioeconomic challenges for weight management in the older adult. Attendees will participate in case-based learning scenarios via the audience response system and an interactive activity that will increase familiarity with the risks and benefits of anti-obesity medications.

Disclosures 

Target Audience
These recertification activities are intended for the Board Certified Ambulatory Care Pharmacist (BCACP) and the Board Certified Geriatric Pharmacist (BCGP) and those interested in patient access to reproductive healthcare, updates in the management of chronic kidney disease, hypercholesterolemia treatment recommendations, and treating obesity in older adults.

Learning Objectives
Learning Objectives 

The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

The American College of Clinical Pharmacy and the American Society of Health-System Pharmacists are approved by BPS as a provider for the recertification of BCACP.

BCACP Clinical Session
Changing the Way Patients Access Reproductive Healthcare
Activity Number: 0217-9999-23-077-H01-P
Contact Hours: 2.00
Activity Type: Application-Based Activity

BCACP/BCGP Clinical Session
Filtering Out the Old, and Reabsorbing the New: Updates in the Management of Chronic Kidney Disease
Activity Number: Activity Number: 0217-9999-23-078-H01-P
Contact Hours: 1.00
Activity Type: Application-Based Activity

BCACP/BCGP Clinical Session
The Cholesterol Limbo: How Low Should You Go?
Activity Number: 0204-9999-23-290-H01-P
Contact Hours: 1.50
Activity Type: Application-Based Activity

BCACP/BCGP Clinical Session
Weighing In: The Risks and Benefits of Treating Obesity in Adults and Older Adults
Activity Number: 0204-9999-23-327-H01-P
Contact Hours: 1.50
Activity Type: Application-Based Activity

To be eligible to earn continuing pharmacy education credit, learners must purchase the product, review all content, successfully complete, submit and pass the web-based posttest associated with each module within the course by December 17, 2026. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed.

National Association of Boards of Pharmacy - CPE Monitor Service

Provided through the collaborative efforts of the National Association of Boards of Pharmacy (NABP), the Accreditation Council for Pharmacy Education (ACPE), and ACPE-accredited providers, the CPE Monitor Service allows you to electronically keep track of continuing pharmacy education (CPE) credits from ACPE-accredited providers. ACPE-accredited providers, like ACCP, are responsible for transmitting this information to NABP to be stored in the CPE Monitor system. Statements of credit will be available at CPE Monitor, nabp.pharmacy/cpe-monitor-service/, within 2–3 business days after completion of this activity. For more information on CPE Monitor please visit nabp.pharmacy/cpe-monitor-service/.

To transfer these credits to CPE Monitor on your behalf your NABP e-Profile ID Number and date of birth must be listed on your ACCP account. To verify or update this information in your ACCP account, visit Licensure/Certification. Be sure to save your changes at the bottom of the page.

Some international pharmacists do not use the CPE Monitor service. To verify or update this information in your ACCP account, visit Licensure/Certification. Check the box “I am an international pharmacist or I am not licensed to practice in the United States, and do not have an NABP e-Profile ID.” Be sure to save your changes at the bottom of the page.

   

To be eligible to earn BCACP and BCGP recertification credit, participants must purchase the recertification version of this course, review all content, successfully complete, submit and pass the web-based posttest associated with each module by December 17, 2024. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed.

The passing point to earn BCACP and BCGP recertification credit is based on an expert analysis of the assessment items in each posttest module. Any posttest submitted before the Specialty Recertification Credit posttest deadline that meets this passing point will earn BCACP and BCGP recertification credits. These credits will be assigned as of the date of test submission.

All participants must have a Board of Pharmacy Specialties (BPS) board certification credential number, BPS ID Number, and a BPS expiration date on file with ACCP for reporting purposes. To verify or update this information in your ACCP account, visit Licensure/Certification. Be sure to save your changes at the bottom of the page.

For statements of recertification credit, visit www.bpsweb.org. Questions regarding the number of hours required for BCACP or BCGP recertification should be directed to BPS at (202) 946-5026 or www.bpsweb.org.

• Internet browser
• Adobe Reader (available free)

The American College of Clinical Pharmacy does not solicit or accept external commercial/financial support for its continuing pharmacy education activities. No commercial/financial support has been solicited or accepted for this activity.